Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tylenol/aspirin ad

This article was originally published in The Tan Sheet

Executive Summary

McNeil Consumer & Specialty Pharmaceuticals touts concomitant acetaminophen and aspirin use with a "Buddy System" print ad appearing in the July 7 New England Journal of Medicine. The ad shows a box of St. Joseph's low-dose aspirin with the statement, "Contains the dosage recommended most by doctors for effective cardiac prevention." The product is paired with Tylenol Arthritis Pain, which "has not been shown to increase the risk of GI bleeding in people taking aspirin, the way NSAIDs sometimes can," copy notes. The ad echoes a 2004 campaign advocating Tylenol over ibuprofen for low-dose aspirin users (1"The Tan Sheet" April 5, 2004, p. 7)...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS098440

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel